Screener
Vir Biotechnology, Inc. VIR License and collaboration revenue — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| License and collaboration revenue | $238,935 | $(495) | $238,894 | $(565) |
| Grant revenue | 11 | 183 | 23 | 1,421 |
| Other revenue | — | 1,526 | — | 3,390 |
| Total revenues | 238,946 | 1,214 | 238,917 | 4,246 |
| Operating expenses: | ||||
| Cost of revenue | — | 11 | — | 11 |
| Research and development | 135,283 | 97,509 | 244,205 | 216,154 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s license and collaboration revenue — total revenues?
- Vir Biotechnology, Inc. (VIR) reported license and collaboration revenue — total revenues of $238.94M in Q2 2026.
- How has Vir Biotechnology, Inc.'s license and collaboration revenue — total revenues changed year-over-year?
- Vir Biotechnology, Inc.'s license and collaboration revenue — total revenues increased by 48369.7% year-over-year, from -$495K to $238.94M.
- What does license and collaboration revenue — total revenues mean?
- This metric represents the total revenue generated from licensing intellectual property and entering into strategic research or development collaborations with third-party partners. It reflects the company's ability to monetize its proprietary technology platforms and pipeline assets through external partnerships rather than solely through direct product sales. This revenue stream is a critical indicator of the company's success in validating its scientific platforms and securing non-dilutive capital to fund ongoing research and development activities.
Ask your AI about Vir Biotechnology, Inc.'s license and collaboration revenue — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude